Amoxicillin and Clarithromycin Mucoadhesive Delivery System for Helicobacter pylori Infection in a Mouse Model: Characterization, Pharmacokinetics, and Efficacy
Authors:
- Isabel VillegasIVIsabel Villegas
- María Ángeles RosilloMRMaría Ángeles Rosillo
- Catalina Alarcón-De-La-LastraCACatalina Alarcón-De-La-Lastra
- Victoria Vázquez-RománVVVictoria Vázquez-Román
- Maria LlorenteMLMaria Llorente
- Susana SánchezSSSusana Sánchez
- Ana Gloria GilAGAna Gloria Gil
- Pilar AlcaldePAPilar Alcalde
- Esther GonzálezEGEsther González
- Elisabet RosellERElisabet Rosell
- Carles NietoCNCarles Nieto
- Francisco Fernandez-CamposFrancisco Fernandez-Campos
Open Access
- 24 January 2021
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (2) , 153
Abstract
Helicobacter pylori is the main pathogen responsible for gastric ulcers and a predisposing factor of stomach cancer. Although current treatment is usually successful, it requires high doses and frequent administration. An innovative mucoadhesive system (Mucolast®) loaded with amoxicillin and clarithromycin is proposed to improve the efficacy of treatment against H. pylori. The drug product was optimized based on its viscoelastic properties to obtain long-term stability of the vehicle. The drug release mechanisms were different for both antibiotics based on their solubilization status. A systemic and stomach pharmacokinetic profile was obtained after three different doses were administered to mice, obtaining similar systemic exposure levels but an increase in drug concentration in the stomach. The efficacy results in mice infected with H. pylori also demonstrated the superiority of the antibiotics when administered in Mucolast®, as shown by the bacterial count in stomach tissue and under histopathological and biochemical evaluation. The proposed treatment was efficacious and safe and is presented as a realistic alternative to current treatment options to improve patient compliance and to reduce bacterial resistance.Keywords
Funding Information
- Ministerio de Ciencia e Innovación (RTC-2015-4437-1)
This publication has 31 references indexed in Scilit:
- Combating Helicobacter Pylori Infections with Mucoadhesive Nanoparticles Loaded with Garcinia Mangostana ExtractNanomedicine, 2014
- Dual drug delivery system for targeting H. pylori in the stomach: preparation and in vitro characterization of amoxicillin-loaded Carbopol® nanospheresInternational Journal of Nanomedicine, 2012
- Anti-Helicobacter pylori Potential of Artemisinin and Its DerivativesAntimicrobial Agents and Chemotherapy, 2012
- Amoxicillin Loaded Chitosan–Alginate Polyelectrolyte Complex Nanoparticles as Mucopenetrating Delivery System for H. PyloriScientia Pharmaceutica, 2011
- DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution ProfilesThe AAPS Journal, 2010
- Clarithromycin- and omeprazole-containing gliadin nanoparticles for the treatment ofHelicobacter pyloriJournal of Drug Targeting, 2008
- Helicobacter pylori VacA Enhances Prostaglandin E 2 Production through Induction of Cyclooxygenase 2 Expression via a p38 Mitogen-Activated Protein Kinase/Activating Transcription Factor 2 Cascade in AZ-521 CellsInfection and Immunity, 2007
- Pathogenesis ofHelicobacter pyloriInfectionClinical Microbiology Reviews, 2006
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976